Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 3—March 2011


Livestock-associated Methicillin-Resistant Staphylococcus aureus in Humans, Europe

Brigitte A.G.L. van CleefComments to Author , Dominique L. Monnet, Andreas Voss, Karina Krziwanek, Franz Allerberger, Marc Struelens, Helena Zemlickova, Robert L. Skov, Jaana Vuopio-Varkila, Christiane Cuny, Alexander W. Friedrich, Iris Spiliopoulou, Judit Pászti, Hjordis Hardardottir, Angela Rossney, Angelo Pan, Annalisa Pantosti, Michael Borg, Hajo Grundmann, Manica Mueller-Premru, Barbro Olsson-Liljequist, Andreas Widmer, Stephan Harbarth, Alexander Schweiger, Serhat Unal, and Jan A.J.W. Kluytmans
Author affiliations: Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (B.A.G.L. van Cleef, H. Grundmann); VU University Medical Centre, Amsterdam, the Netherlands (B.A.G.L. van Cleef, J.A.J.W. Kluytmans); European Centre for Disease Prevention and Control, Stockholm, Sweden (D.L. Monnet); Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands (A. Voss); Elisabethinen Hospital, Linz, Austria (K. Krziwanek); Österreichische Agentur für Gesundheit und Ernährungssicherheit, Wien, Austria (F. Allerberger); Université Libre de Bruxelles Hôpital Erasme, Brussels, Belgium (M. Struelens); Statni Zdravotni Ustav, Praha, Czech Republic (H. Zemlickova); Statens Serum Institut, Copenhagen, Denmark (R.L. Skov); National Public Health Institute, Helsinki, Finland (J. Vuopio-Varkila); Robert Koch Institute, Wernigerode, Germany (C. Cuny); Institute of Hygiene of the University Hospital, Münster, Germany (A.W. Friedrich); University of Patras, Patras, Greece (I. Spiliopoulou); National Center for Epidemiology, Budapest, Hungary (J. Pászti); Landspitali University Hospital, Reykjavik, Iceland (H. Hardardottir); National MRSA Reference Laboratory, St. James's Hospital, Dublin, Ireland (A. Rossney); Istituti Ospitalieri di Cremona, Cremona, Italy (A. Pan); Istituto Superiore di Sanità, Rome, Italy (A. Pantosti); Mater Dei Hospital, Msida, Malta (M. Borg); Medical Faculty, Ljubljana, Slovenia (M. Mueller-Premru); Swedish Institute for Infectious Disease Control, Solna, Sweden (B. Olsson-Liljequist); University Hospital, Basel, Switzerland (A. Widmer); Hôpitaux Universitaires de Genève, Geneva, Switzerland (S. Harbarth); University Hospital Zürich, Zürich, Switzerland (A. Schweiger); Hacettepe University, Ankara, Turkey (S. Unal); Amphia Hospital, Breda, the Netherlands (J.A.J.W. Kluytmans)

Main Article

Table 2

Distribution of typed MRSA ST398 and other MRSA clinical isolates, by body site, 7 European countries, 2007*

Sample source No. (%) typed clinical isolates
p value†
MRSA ST398, n = 113 Other MRSA,
n = 3,435
Blood 2 (1.8) 343 (10.0) 0.004
Respiratory tract 20 (17.7) 451 (13.1) 0.16
Skin and wound 76 (67.3) 2,312 (67.3) 0.99
Urinary tract 6 (5.3) 173 (5.0) 0.90
Other 9 (8.0) 156 (4.5) 0.09

*Only data from 9 national or regional laboratories in the 7 countries that reported clinical isolates and typed all these isolates were included. Boldface indicates statistical significance (p<0.05). MRSA, methicillin-resistant Staphylococcus aureus; ST398, sequence type 398.
†χ2 test.

Main Article

1Current affiliation: European Centre for Disease Prevention and Control, Stockholm, Sweden.

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO